1 [Laennec versus Forbes : tied for the score ! How technology helps us interpret auscultation].

2 A Novel Deep Learning Algorithm for the Automatic Detection of High-Grade Gliomas on T2-Weighted Magnetic Resonance Images: A Preliminary Machine Learning Study.

3 Mechanisms involved in the cardioprotective effect of avocado consumption: A systematic review

4 Plant-Based Diets for Cardiovascular Disease Prevention: All Plant Foods Are Not Created Equal.

5 A review of gene-by-air pollution interactions for cardiovascular disease, risk factors, and biomarkers.

6 A systematic review of cardiovascular responses associated with ambient black carbon and fine particulate matter.

7 Composition and cardioprotective effects of Primula veris L. solid herbal extract in experimental chronic heart failure.

8 Mushroom consumption, biomarkers, and risk of cardiovascular disease and type 2 diabetes: a prospective cohort study of US women and men.

9 Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries.

10 Role of Big Data in Cardiovascular Research.

11 Challenges in Implementing Optimal Echocardiographic Screening in Cardio-Oncology.

12 Endurance Exercise Attenuates Doxorubicin-induced Cardiotoxicity.

13 Evaluation of the phytochemical composition and protective activities of methanolic extracts of and (Lipsky) Wagenitz on cardiomyocytes treated with doxorubicin.

14 Mechanisms Underlying Spontaneous Action Potential Generation Induced by Catecholamine in Pulmonary Vein Cardiomyocytes: A Simulation Study.

15 Enhancing cardiovascular artificial intelligence (AI) research in the Netherlands: CVON-AI consortium.

16 Morning plasma cortisol as a cardiovascular risk factor: findings from prospective cohort and Mendelian randomization studies.

17 A Mediterranean Diet Rich in Extra-Virgin Olive Oil Is Associated with a Reduced Prevalence of Nonalcoholic Fatty Liver Disease in Older Individuals at High Cardiovascular Risk.

18 Galectin-3: A Novel Biomarker Predicts Sudden Cardiac Death in Hypertrophic Cardiomyopathy.

19 Recovery of cardiomyopathy induced by ventricular premature beats of paraHisian origin after successful radiofrequency catheter ablation.

20 Galectin-3 correlates with arrhythmogenic right ventricular cardiomyopathy and predicts the risk of ventricular -arrhythmias in patients with implantable defibrillators.

21 Distinguishing Right Ventricular Cardiomyopathy From Idiopathic Right Ventricular Outflow Tract Tachycardia with T-wave Alternans.

22 Cardiotrophin-1: A new predictor of atrial fibrillation relapses after successful cardioversion.

23 Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.

24 Nuclear cardiology in the literature: A selection of recent, original research papers

25 Comparison of zebrafish larvae and hiPSC cardiomyocytes for predicting drug induced cardiotoxicity in humans.

26 Assessment of Causal Direction Between Gut Microbiota-Dependent Metabolites and Cardiometabolic Health: Abi-Directional Mendelian Randomisation Analysis.

27 Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes.

28 Novel Oral Anticoagulants for Primary Stroke Prevention in Hypertrophic Cardiomyopathy Patients With Atrial Fibrillation.

29 Use of pulsed electron avalanche knife (PEAK) PlasmaBlade™ in patients undergoing implantation of subcutaneous implantable cardioverter-defibrillator.

30 Novel anticoagulants versus vitamin K antagonists for cardioversion of non- valvular atrial fibrillation – a meta-analysis of more than 17000 patients

31 Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients Undergoing Cardioversion for Atrial Fibrillation: a Systematic Review and Meta-analysis

32 Vitamin K status and cardiovascular events or mortality: A meta-analysis

33 Comment on “Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis”

34 Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysis.

35 A case of Brucella melitensis endocarditis in a patient with cardiovascular implantable electronic device

36 In situ detection of Chlamydia pneumoniae, C. trachomatis, and cytokines among cardiovascular diseased patients from the Amazon region of Brazil

37 Current insights of inspiratory muscle training on the cardiovascular system: a systematic review with meta-analysis

38 Masked hypertension and cardiovascular outcomes: an updated systematic review and meta-analysis

39 Preeclampsia and cardiovascular disease: interconnected paths that enable detection of the subclinical stages of obstetric and cardiovascular diseases

40 Consumption of nattokinase is associated with reduced blood pressure and von Willebrand factor, a cardiovascular risk marker: results from a randomized, double-blind, placebo-controlled, multicenter North American clinical trial

41 The effect of aged garlic extract on blood pressure and other cardiovascular risk factors in uncontrolled hypertensives: the AGE at Heart trial

42 Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine

43 Combining antihypertensive and antihyperlipidemic agents – optimizing cardiovascular risk factor management

44 Impact of olmesartan on blood pressure, endothelial function, and cardiovascular outcomes

45 Update on the role of candesartan in the optimal management of hypertension and cardiovascular risk reduction

46 Can nocturnal hypertension predict cardiovascular risk?

47 Impact of dyslipidemia on cardiovascular risk stratification of hypertensive patients and association of lipid profile with other cardiovascular risk factors: results from the ICEBERG study

48 Prevalence and characteristics of dysfunction of right ventricle in peripartum cardiomyopathy

49 Peripartum cardiomyopathy: challenges and solutions

50 Frequency of coronary artery stenosis in patients with asymptomatic familial hypercholesterolemia and its association with carotid intimal thickness and cardio-ankle vascular index [Corrigendum]

51 Frequency of coronary artery stenosis in patients with asymptomatic familial hypercholesterolemia and its association with carotid intimal thickness and cardio-ankle vascular index

52 Left atrial appendage closure devices for cardiovascular risk reduction in atrial fibrillation patients

53 Implantable cardioverter defibrillators: state of the art

54 Current perspectives on cardioembolic ischemic stroke in very old patients

55 Takotsubo cardiomyopathy: etiology, diagnosis, and optimal management

56 Role of vitamins in cardiovascular health and disease

57 Clinical utility of ivabradine in cardiovascular disease management: current status

58 Current concepts in the management of cardiogenic shock

59 Impact of rivaroxaban on stent thrombosis and secondary prevention of cardiovascular events in acute coronary syndrome

60 Possible space flight-induced catecholamine cardiomyopathy: Neil Armstrong's last 20 lunar minutes

61 Transitioning from population to individualized preventive cardiology

62 Clinical utility of low-density lipoprotein particle measurement in management of cardiovascular disease: a case report

63 High-density lipoproteins: a novel therapeutic target for cardiovascular disease

64 A Cox-Based Risk Prediction Model for Early Detection of Cardiovascular Disease: Identification of Key Risk Factors for the Development of a 10-Year CVD Risk Prediction

65 Pros and Cons of Aspirin Prophylaxis for Prevention of Cardiovascular Events in Kidney Transplantation and Review of Evidence

66 The Cardio- and Neuroprotective Effects of Corvitin and 2-Oxoglutarate in Rats with Pituitrin-Isoproterenol-Induced Myocardial Damage

67 Concordance between the Different Cardiovascular Risk Scores in People with Rheumatoid Arthritis and Psoriasis Arthritis

68 Clozapine-Induced Cardiotoxicity Presenting as Sepsis: A Case Report and Literature Review

69 A case of Brucella melitensis endocarditis in a patient with cardiovascular implantable electronic device

70 In situ detection of Chlamydia pneumoniae, C. trachomatis, and cytokines among cardiovascular diseased patients from the Amazon region of Brazil

71 Current insights of inspiratory muscle training on the cardiovascular system: a systematic review with meta-analysis

72 Masked hypertension and cardiovascular outcomes: an updated systematic review and meta-analysis

73 Preeclampsia and cardiovascular disease: interconnected paths that enable detection of the subclinical stages of obstetric and cardiovascular diseases

74 Consumption of nattokinase is associated with reduced blood pressure and von Willebrand factor, a cardiovascular risk marker: results from a randomized, double-blind, placebo-controlled, multicenter North American clinical trial

75 The effect of aged garlic extract on blood pressure and other cardiovascular risk factors in uncontrolled hypertensives: the AGE at Heart trial

76 Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine

77 Combining antihypertensive and antihyperlipidemic agents – optimizing cardiovascular risk factor management

78 Impact of olmesartan on blood pressure, endothelial function, and cardiovascular outcomes

79 Update on the role of candesartan in the optimal management of hypertension and cardiovascular risk reduction

80 Can nocturnal hypertension predict cardiovascular risk?

81 Impact of dyslipidemia on cardiovascular risk stratification of hypertensive patients and association of lipid profile with other cardiovascular risk factors: results from the ICEBERG study

82 Prevalence and characteristics of dysfunction of right ventricle in peripartum cardiomyopathy

83 Peripartum cardiomyopathy: challenges and solutions

84 Frequency of coronary artery stenosis in patients with asymptomatic familial hypercholesterolemia and its association with carotid intimal thickness and cardio-ankle vascular index [Corrigendum]

85 Frequency of coronary artery stenosis in patients with asymptomatic familial hypercholesterolemia and its association with carotid intimal thickness and cardio-ankle vascular index

86 Left atrial appendage closure devices for cardiovascular risk reduction in atrial fibrillation patients

87 Implantable cardioverter defibrillators: state of the art

88 Current perspectives on cardioembolic ischemic stroke in very old patients

89 Takotsubo cardiomyopathy: etiology, diagnosis, and optimal management

90 Role of vitamins in cardiovascular health and disease

91 Clinical utility of ivabradine in cardiovascular disease management: current status

92 Current concepts in the management of cardiogenic shock

93 Impact of rivaroxaban on stent thrombosis and secondary prevention of cardiovascular events in acute coronary syndrome

94 Possible space flight-induced catecholamine cardiomyopathy: Neil Armstrong's last 20 lunar minutes

95 Transitioning from population to individualized preventive cardiology

96 Clinical utility of low-density lipoprotein particle measurement in management of cardiovascular disease: a case report

97 High-density lipoproteins: a novel therapeutic target for cardiovascular disease

98 Proof of Principle that Molecular Modeling Followed by a Biophysical Experiment Can Develop Small Molecules that Restore Function to the Cardiac Thin Filament in the Presence of Cardiomyopathic Mutations.

99 Leukodepleted Packed Red Blood Cells Transfusion in Patients Undergoing Major Cardiovascular Surgical Procedure: Systematic Review and Meta-Analysis

100 Music therapy-induced changes in salivary cortisol level are predictive of cardiovascular mortality in patients under maintenance hemodialysis

101 Incretin Hormones: The Link between Glycemic Index and Cardiometabolic Diseases.

Keyword Connections

Journals

Research Groups

Bibliographies